Plateau phase in multiple myeloma: an analysis of long-term follow-up of 432 patients

British Journal of Haematology

Volumn 92, Issue 4, 1996, Pages 834-839

  Oivanen, Tiina M ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

myeloma; plateau phase; prognosis; survival

Indexed keywords

CYCLOPHOSPHAMIDE; HEMOGLOBIN; LOMUSTINE; MELPHALAN; METHYLPREDNISOLONE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030005782     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.413952.x     Document Type: Article

References (20)

1. Alexanian, R., Gehan, K., Haut, A., Saiki, J. & Weick, J. (1978) Unmaintained remissions in multiple myeloma. Blood, 51, 1005-1011.
2. Belch, A., Shelley, W., Bergsagel, D., Wilson, K., Klimo, P., White, D. & Willan, A. (1988) A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients. British Journal of Cancer, 57, 94-99.
3. Child, J.A. (1994) Evolving strategies for the treatment of myelomatosis. British Journal of Haematology, 88, 672-678.
4. Chronic Leukemia-Myeloma Task Force (1973) Proposed guidelines for clinical studies. Cancer Chemotherapy Reports, 4, 145-158.
5. Durie, B.G.M., Russell, D.H. & Salmon, S.E. (1980) Reappraisal of plateau phase in myeloma. Lancet, ii, 65-68.
6. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
7. Durie, B.G.M. & Salmon, S.E. (1977) Multiple myeloma, macroglobulinaemia and monoclonal gammopathies. Recent Advances in Haematology (ed. by A. V. Hoffbrand, H. C. Brain and J. Hirsh), pp. 243-261. Churchill Livingstone, Edinburgh.
8. Durie, B.G.M. & Salmon, S.E. (1982) The current status and future prospects of treatment for multiple myeloma. Clinics in Haematology, 11, 181-210.
9. Finnish Leukaemia Group (1985) Aggressive combination chemotherapy in multiple myeloma: a multicentre trial. Scandinavian Journal of Haematology, 35, 205-209.
10. Finnish Leukaemia Group (1987) Treatment of multiple myeloma with an intensive five-drug combination or intermittent melphalan and prednisone: a randomised multicentre trial. European Journal of Haematology, 38, 50-54.
11. Finnish Leukaemia Group (1989) Treatment of multiple myeloma in old patients. European Journal of Haematology, 43, 328-331.
12. Finnish Leukaemia Group (1993) Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. European Journal of Haematology, 51, 98-101.
13. Gregory, W.M., Richards, M.,A. & Malpas, J.S. (1992) Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. Journal of Clinical Oncology, 10, 334-342.
14. Hjorth, M., Westin, J., Dahl, I.,M.S., Gimsing, P., Hippe, E., Holmberg, E., Lamvik, J., Lanng Nielsen, J., Löfvenberg, E., Palva, I.P., Rödjer, S., Talstad, I., Turesson, I., Wislöff, F. & Zador, G. (1995) Interferon alfa-2b in addition to melphalanprednisone for initial and maintenance treatment in multiple myeloma: a randomized Nordic trial. Annals of Internal Medicine, in press.
15. Joshua, D.E., Snowdon, I., Gibson, J., Hand, H., Brown, R., Warburton, P., Kulkarni, A., Vincent, P., Young, G., Gatenby, P., Basten, A. & Kronenberg, H. (1991) Multiple myeloma: plateau phase revisited. Hematology Reviews, 5, 59-66.
16. Karjalainen, S. & Palva, I. (1989) Do protocols improve end results? A study of survival of patients with multiple myeloma in Finland. British Medical Journal 229, 1069-1072.
17. MacLennan, I.C.M., Chapman, C., Dunn, J. & Kelly, K. (1992) Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. Lancet, 339, 200-205.
18. MacLennan, I.C.M., Drayson, M. & Dunn, J. (1994) Multiple myeloma. British Medical Journal, 308, 1033-1036.
19. Salmon, S.E. (1973) Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Seminars in Hematology, 10, 135-129.
20. Salmon, S.E. (1975) Expansion of the growth fraction in multiple myeloma with alkylating agents. Blood, 45, 119-129.